Literature DB >> 22610003

The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis.

Hannah P Kim1, R Brooks Vance, Nicholas J Shaheen, Evan S Dellon.   

Abstract

BACKGROUND & AIMS: Endoscopic findings such as esophageal rings, strictures, narrow-caliber esophagus, linear furrows, white plaques, and pallor or decreased vasculature might indicate the presence of eosinophilic esophagitis (EoE). We aimed to determine the prevalence and diagnostic utility of endoscopic features of EoE.
METHODS: We conducted a systematic review and meta-analysis. PubMed, EMBASE, and gastrointestinal meeting abstracts were searched to identify studies that included more than 10 patients with EoE and reported endoscopic findings. Pooled prevalence, sensitivity, specificity, and predictive values were calculated using random- and mixed-effects models.
RESULTS: The search yielded 100 articles and abstracts on 4678 patients with EoE and 2742 without (controls). In subjects with EoE, the overall pooled prevalence was as follows: esophageal rings, 44%; strictures, 21%; narrow-caliber esophagus, 9%; linear furrows, 48%; white plaques, 27%; and pallor/decreased vasculature, 41%. Substantial heterogeneity existed among studies. Results from endoscopy examinations were normal in 17% of patients, but this number decreased to 7% when the analysis was limited to prospective studies (P < .05). Overall levels of sensitivity were modest, ranging from 15% to 48%, whereas levels of specificity were greater, ranging from 90% to 95%. Positive predictive values ranged from 51% to 73% and negative predictive values ranged from 74% to 84%.
CONCLUSIONS: There is heterogeneity among studies in the reported prevalence of endoscopic findings in patients with EoE, but in prospective studies at least 1 abnormality was detected by endoscopy in 93% of patients. The operating characteristics of endoscopic findings alone are inadequate for diagnosis of EoE. Esophageal biopsy specimens should be obtained from all patients with clinical features of EoE, regardless of the endoscopic appearance of the esophagus.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22610003      PMCID: PMC3424367          DOI: 10.1016/j.cgh.2012.04.019

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  101 in total

1.  Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis.

Authors:  Samer M A Abu-Sultaneh; Paul Durst; Virginia Maynard; Yoram Elitsur
Journal:  Dig Dis Sci       Date:  2010-05-11       Impact factor: 3.199

2.  Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?

Authors:  S K Gupta; J F Fitzgerald; S K Chong; J M Croffie; M H Collins
Journal:  Gastrointest Endosc       Date:  1997-06       Impact factor: 9.427

Review 3.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

4.  Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

Authors:  Amindra S Arora; Jean Perrault; Thomas C Smyrk
Journal:  Mayo Clin Proc       Date:  2003-07       Impact factor: 7.616

5.  Esophageal eosinophilia in children with dysphagia.

Authors:  Ka Ming Cheung; Mark R Oliver; Donald J S Cameron; Anthony G Catto-Smith; Chung W Chow
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-10       Impact factor: 2.839

6.  Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.

Authors:  Wael N Sayej; Raza Patel; Robert D Baker; Eduardo Tron; Susan S Baker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-10       Impact factor: 2.839

Review 7.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

8.  Histopathologic variability in children with eosinophilic esophagitis.

Authors:  Ameesh Shah; Amir F Kagalwalla; Nirmala Gonsalves; Hector Melin-Aldana; B U K Li; Ikuo Hirano
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

Review 9.  Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review.

Authors:  Evan S Dellon; Ademola Aderoju; John T Woosley; Robert S Sandler; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2007-07-07       Impact factor: 10.864

10.  Clinical and endoscopic features of eosinophilic esophagitis in adults.

Authors:  John Croese; Stephen K Fairley; John W Masson; André K H Chong; David A Whitaker; Peter A Kanowski; Neal I Walker
Journal:  Gastrointest Endosc       Date:  2003-10       Impact factor: 9.427

View more
  90 in total

Review 1.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

2.  A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.

Authors:  Evan S Dellon; Hannah P Kim; Sarah L W Sperry; David A Rybnicek; John T Woosley; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2013-11-23       Impact factor: 9.427

3.  Eosinophilic esophagitis--recognition, diet and drugs.

Authors:  Marietta Iacucci; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-08       Impact factor: 3.522

4.  Eosinophilic esophagitis and proton pump inhibitors: controversies and implications for clinical practice.

Authors:  W Asher Wolf; Evan S Dellon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

5.  Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.

Authors:  Dijin Jiao; Norihisa Ishimura; Riruke Maruyama; Noriyoshi Ishikawa; Mamiko Nagase; Naoki Oshima; Masahito Aimi; Eiko Okimoto; Hironobu Mikami; Daisuke Izumi; Mayumi Okada; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2016-04-23       Impact factor: 7.527

6.  Epidemiology of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2014-03-19       Impact factor: 3.806

7.  Mucosal Impedance Measurements Differentiate Pediatric Patients With Active Versus Inactive Eosinophilic Esophagitis.

Authors:  Mary Allyson Lowry; Michael F Vaezi; Hernan Correa; Tina Higginbotham; James C Slaughter; Sari Acra
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-08       Impact factor: 2.839

Review 8.  Eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2012-12-27       Impact factor: 3.806

9.  Pseudodiverticulosis: a rare presentation of eosinophilic esophagitis.

Authors:  Pradeep Reddy Kathi; Maher Tama; Nikhila Thammineni; Murray Ehrinpreis
Journal:  Clin J Gastroenterol       Date:  2019-09-20

10.  Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.

Authors:  Seema Aceves; Ikuo Hirano; Glenn T Furuta; Margaret H Collins
Journal:  Semin Immunopathol       Date:  2012-07-29       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.